Reduced dNTP Binding Affinity of 3TC-resistant M184I HIV-1 Reverse Transcriptase Variants Responsible for Viral Infection Failure in Macrophage*

We characterized HIV-1 reverse transcriptase (RT) variants either with or without the (-)-2′,3′-deoxy-3′-thiacytidine-resistant M184I mutation isolated from a single HIV-1 infected patient. First, unlike variants with wild-type M184, M184I RT variants displayed significantly reduced DNA polymerase activity at low dNTP concentrations, which is indicative of reduced dNTP binding affinity. Second, the M184I variant displayed a ∼10- to 13-fold reduction in dNTP binding affinity, compared with the Met-184 variant. However, the kpol values of these two RTs were similar. Third, unlike HIV-1 vectors with wild-type RT, the HIV-1 vector harboring M184I RT failed to transduce cell types containing low dNTP concentrations, such as human macrophage, likely due to the reduced DNA polymerization activity of the M184I RT under low cellular dNTP concentration conditions. Finally, we compared the binary complex structures of wild-type and M184I RTs. The Ile mutation at position 184 with a longer and more rigid β-branched side chain, which was previously known to alter the RT-template interaction, also appears to deform the shape of the dNTP binding pocket. This can restrict ground state dNTP binding and lead to inefficient DNA synthesis particularly at low dNTP concentrations, ultimately contributing to viral replication failure in macrophage and instability in vivo of the M184I mutation.

[1]  P. Boyer,et al.  Apparent Defects in Processive DNA Synthesis, Strand Transfer, and Primer Elongation of Met-184 Mutants of HIV-1 Reverse Transcriptase Derive Solely from a dNTP Utilization Defect* , 2008, Journal of Biological Chemistry.

[2]  S. Wurtzer,et al.  Human Immunodeficiency Virus Type 1: Resistance to Nucleoside Analogues and Replicative Capacity in Primary Human Macrophages , 2007, Journal of Virology.

[3]  C. Mathé,et al.  L-nucleoside enantiomers as antivirals drugs: a mini-review. , 2006, Antiviral research.

[4]  Pauline E. Chugh,et al.  Modification of Human Immunodeficiency Virus Type 1 Reverse Transcriptase to Target Cells with Elevated Cellular dNTP Concentrations* , 2006, Journal of Biological Chemistry.

[5]  F. Ceccherini‐Silberstein,et al.  Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages. , 2005, The Journal of antimicrobial chemotherapy.

[6]  Baek Kim,et al.  Mechanistic Differences in RNA-dependent DNA Polymerization and Fidelity between Murine Leukemia Virus and HIV-1 Reverse Transcriptases* , 2005, Journal of Biological Chemistry.

[7]  R. Bambara,et al.  Macrophage Tropism of HIV-1 Depends on Efficient Cellular dNTP Utilization by Reverse Transcriptase* , 2004, Journal of Biological Chemistry.

[8]  P. Boyer,et al.  Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis. , 2004, Virology.

[9]  L. M. Mansky,et al.  A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis. , 2004, Biochemistry.

[10]  K. White,et al.  Mechanistic Basis for Reduced Viral and Enzymatic Fitness of HIV-1 Reverse Transcriptase Containing Both K65R and M184V Mutations* , 2004, Journal of Biological Chemistry.

[11]  T. Traut,et al.  Physiological concentrations of purines and pyrimidines , 1994, Molecular and Cellular Biochemistry.

[12]  R. Bambara,et al.  Mechanistic Understanding of an Altered Fidelity Simian Immunodeficiency Virus Reverse Transcriptase Mutation, V148I, Identified in a Pig-tailed Macaque* , 2003, Journal of Biological Chemistry.

[13]  R. Bambara,et al.  Mechanistic Role of Residue Gln151 in Error Prone DNA Synthesis by Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase (RT) , 2002, The Journal of Biological Chemistry.

[14]  N. Pedersen,et al.  Virulence and Reduced Fitness of Simian Immunodeficiency Virus with the M184V Mutation in Reverse Transcriptase , 2002, Journal of Virology.

[15]  A. Hizi,et al.  The processivity and fidelity of DNA synthesis exhibited by the reverse transcriptase of bovine leukemia virus. , 2002, European journal of biochemistry.

[16]  B. Canard,et al.  Mechanism-based Suppression of Dideoxynucleotide Resistance by K65R Human Immunodeficiency Virus Reverse Transcriptase Using an α-Boranophosphate Nucleoside Analogue* , 2001, The Journal of Biological Chemistry.

[17]  E. Adman,et al.  Molecular architecture of the mutagenic active site of human immunodeficiency virus type 1 reverse transcriptase: roles of the beta 8-alpha E loop in fidelity, processivity, and substrate interactions. , 2000, Biochemistry.

[18]  S. Frost,et al.  Evolution of Lamivudine Resistance in Human Immunodeficiency Virus Type 1-Infected Individuals: the Relative Roles of Drift and Selection , 2000, Journal of Virology.

[19]  S. Sarafianos,et al.  The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase. , 2000, Journal of molecular biology.

[20]  K. Parnell,et al.  Mechanism of Inhibition of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase by d4TTP: an Equivalent Incorporation Efficiency Relative to the Natural Substrate dTTP , 2000, Antimicrobial Agents and Chemotherapy.

[21]  A. D. Clark,et al.  Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Anderson,et al.  Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase. , 1999, Biochemistry.

[23]  K. Anderson,et al.  Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase. , 1999, Biochemistry.

[24]  A. D. Clark,et al.  Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. , 1998, Journal of molecular biology.

[25]  G L Verdine,et al.  Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. , 1998, Science.

[26]  W. C. Drosopoulos,et al.  The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase. , 1998, Nucleic acids research.

[27]  R. Doms,et al.  Chemokines and coreceptors in HIV/SIV-host interactions. , 1998, AIDS.

[28]  M. Wainberg,et al.  Mutations at codon 184 in simian immunodeficiency virus reverse transcriptase confer resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine , 1997, Antimicrobial agents and chemotherapy.

[29]  M. Wainberg,et al.  Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1. , 1997, Nucleic acids research.

[30]  B. Berkhout,et al.  Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase , 1997, Antimicrobial agents and chemotherapy.

[31]  B. Kim Genetic selection in Escherichia coli for active human immunodeficiency virus reverse transcriptase mutants. , 1997, Methods.

[32]  B. Berkhout,et al.  Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase. , 1997, Nucleic acids research.

[33]  W. Keulen,et al.  Reduced replication of 3TC‐resistant HIV‐1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. , 1996, The EMBO journal.

[34]  K. Johnson,et al.  Rapid quench kinetic analysis of polymerases, adenosinetriphosphatases, and enzyme intermediates. , 1995, Methods in enzymology.

[35]  M. Wainberg,et al.  High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase , 1993, Antimicrobial Agents and Chemotherapy.

[36]  M. Bakhanashvili,et al.  Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus. , 1993, Biochemistry.

[37]  S D Kemp,et al.  Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Wainberg,et al.  The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine , 1993, Antimicrobial Agents and Chemotherapy.

[39]  R F Schinazi,et al.  Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides , 1993, Antimicrobial Agents and Chemotherapy.

[40]  K. Johnson,et al.  Conformational coupling in DNA polymerase fidelity. , 1993, Annual review of biochemistry.

[41]  J. DeStefano,et al.  Requirements for strand transfer between internal regions of heteropolymer templates by human immunodeficiency virus reverse transcriptase , 1992, Journal of virology.

[42]  I Sauvaget,et al.  Identification of four conserved motifs among the RNA‐dependent polymerase encoding elements. , 1989, The EMBO journal.

[43]  M. A. McClure,et al.  Origins and Evolutionary Relationships of Retroviruses , 1989, The Quarterly Review of Biology.

[44]  T. Kunkel,et al.  Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro , 1989, Molecular and cellular biology.

[45]  Brendan A. Larder,et al.  Site-specific mutagenesis of AIDS virus reverse transcriptase , 1987, Nature.

[46]  R. Bambara,et al.  On the processive mechanism of Escherichia coli DNA polymerase I. Quantitative assessment of processivity. , 1978, The Journal of biological chemistry.